CompoAtlas

PURESSENTIEL INHALER RESPISTICK

Natural health product licensed in Canada

Licence holder
Laboratoire Puressentiel
NPN or DIN-HM
80058912
Status
Active licence
Licence date
17 March 2015
Revision date
Not provided
Form
Inhalation
Route of administration
Inhalation
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Eucalyptus globulus

Source : Eucalyptus Globulus - leaves

80 %

Non-medicinal ingredients

Huile de Mentha Piperita (Menthe poivrée), Huile essentielle de feuille de Melaleuca leucadendra, Huile essentielle de clou d'Eugenia Caryophyllus, Huile essentielle de Bay, Huile essentielle de feuilles d'Origanum Vulgare, Huile essentielle de fleurs/feuilles de Thymus Vulgaris (Thym), Coton, Huile essentielle de feuilles de Melaleuca alternifolia, Huile essentielle de feuille de Pinus sylvestris, Huile essentielle de lavande dentée, Huile essentielle de sauge, Huile de Lavandula Hybrida, Huile de tige/noix/feuille de Cupressus Sempervirens, Huile essentielle de pelures de Citrus limon, Huile Essentielle de Melaleuca Quinquenervia, Huile essentielle de romarin, Huile essentielle de graines de Pimpinella Anisum (Anis), Menthol, Huile essentielle d'écorce de Cinnamomum Camphora (camphre), Huile essentielle d' Eucalyptus Citriodora

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years3 Inhalation3 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Used in Aromatherapy to help relieve colds/cough.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80058912

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line